Literature DB >> 154894

Immunoregulation in New Zealand mice. I. Failure of the transfer of syngeneic spleen or thymus cells to influence the natural disease in New Zealand mice.

A A Hoffman, R J Harbeck.   

Abstract

Young, syngeneic thymocytes and spleen cells were administered to F1 hybrids of New Zealand Black by New Zealand White (NZB/W) mice beginning at 3 weeks of age and were continuted at 2-week intervals for 8 to 9 months. The development of autoimmunity as assessed by measuring the incidence and level of anti-DNA antibody, the degree of renal involvement, and the survival of recipient mice was evaluated and compared to a control group of animals. No significant differences were noted in these parameters in mice receiving cell transfers as compared to the control group. Therefore, in contrast to other reports, these results suggest that the transfer of young thymus or spleen cells into aging NZB/W mice fails to influence immunoregulation and the subsequent development of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 154894     DOI: 10.1002/art.1780220416

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

Review 1.  Autoimmune diseases: immunopathology and etiopathogenesis.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

2.  Mononuclear-cell pulmonary vasculitis in NZB/W mice. I. Histopathologic evaluation of spontaneously occurring pulmonary infiltrates.

Authors:  C Staszak; R J Harbeck
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

3.  Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice.

Authors:  A N Theofilopoulos; D L Shawler; R A Eisenberg; F J Dixon
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

4.  Establishment of monoclonal antibodies which possess the same characteristics as the naturally occurring thymocytotoxic autoantibodies (NTA).

Authors:  K Tani; H Sakamoto; K Katoh; K Matsunagai; S Yamada; K Okuda; B S Handwerger
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.